Tags

Type your tag names separated by a space and hit enter

Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia.
Vox Sang. 2004 Aug; 87(2):118-23.VS

Abstract

BACKGROUND

Polymorphisms of platelet membrane glycoproteins such as human platelet antigen (HPA)-1b, HPA-2b, the -5T/C Kozak sequence and C807T have been described as risk factors for vascular disease. Vaso-occlusion episodes are a common feature of sickle cell anaemia (SCA), leading to complications such as stroke, acute chest syndrome, avascular head femur necrosis and priapism. Complex interactions are involved in vaso-occlusion, and activated platelets may play an important role. These data raised the question of whether platelet polymorphisms could be implicated in occlusive vascular complications (OVC) of SCA.

MATERIALS AND METHODS

In this study, 97 patients with SCA were analysed in two groups: 34 patients presenting with OVC (SCA-VC) and 63 without these complications (SCA-N). The distribution of the HPA-1, -2 and -5 systems, as well as C807T dimorphism and -5T/C Kozak sequence alleles, was evaluated using DNA-based methods.

RESULTS

Patients of the SCA-VC group showed a higher frequency of the HPA-5b allele (0.324) compared with those of the SCA-N group (0.111) (chi2 = 13.19, P = 0.0002). None of the other polymorphisms, isolated or associated as haplotypes, demonstrated any correlation with the development of OVC in these patients.

CONCLUSIONS

The findings of this study suggest that the HPA-5b allele is a genetic risk factor for the development of OVC in patients with SCA. This allele could be explored as a target for the development of new therapeutic approaches.

Authors+Show Affiliations

Hematology and Hemotherapy Center, State University of Campinas-UNICAMP, São Paulo, Brazil. vagner@unicamp.brNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15355504

Citation

Castro, V, et al. "Polymorphism of the Human Platelet Antigen-5 System Is a Risk Factor for Occlusive Vascular Complications in Patients With Sickle Cell Anemia." Vox Sanguinis, vol. 87, no. 2, 2004, pp. 118-23.
Castro V, Alberto FL, Costa RN, et al. Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang. 2004;87(2):118-23.
Castro, V., Alberto, F. L., Costa, R. N., Lepikson-Neto, J., Gualandro, S. F., Figueiredo, M. S., Annichino-Bizzacchi, J. M., Saad, S. T., & Costa, F. F. (2004). Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sanguinis, 87(2), 118-23.
Castro V, et al. Polymorphism of the Human Platelet Antigen-5 System Is a Risk Factor for Occlusive Vascular Complications in Patients With Sickle Cell Anemia. Vox Sang. 2004;87(2):118-23. PubMed PMID: 15355504.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. AU - Castro,V, AU - Alberto,F L, AU - Costa,R N P, AU - Lepikson-Neto,J, AU - Gualandro,S F M, AU - Figueiredo,M S, AU - Annichino-Bizzacchi,J M, AU - Saad,S T O, AU - Costa,F F, PY - 2004/9/10/pubmed PY - 2005/4/20/medline PY - 2004/9/10/entrez SP - 118 EP - 23 JF - Vox sanguinis JO - Vox Sang. VL - 87 IS - 2 N2 - BACKGROUND: Polymorphisms of platelet membrane glycoproteins such as human platelet antigen (HPA)-1b, HPA-2b, the -5T/C Kozak sequence and C807T have been described as risk factors for vascular disease. Vaso-occlusion episodes are a common feature of sickle cell anaemia (SCA), leading to complications such as stroke, acute chest syndrome, avascular head femur necrosis and priapism. Complex interactions are involved in vaso-occlusion, and activated platelets may play an important role. These data raised the question of whether platelet polymorphisms could be implicated in occlusive vascular complications (OVC) of SCA. MATERIALS AND METHODS: In this study, 97 patients with SCA were analysed in two groups: 34 patients presenting with OVC (SCA-VC) and 63 without these complications (SCA-N). The distribution of the HPA-1, -2 and -5 systems, as well as C807T dimorphism and -5T/C Kozak sequence alleles, was evaluated using DNA-based methods. RESULTS: Patients of the SCA-VC group showed a higher frequency of the HPA-5b allele (0.324) compared with those of the SCA-N group (0.111) (chi2 = 13.19, P = 0.0002). None of the other polymorphisms, isolated or associated as haplotypes, demonstrated any correlation with the development of OVC in these patients. CONCLUSIONS: The findings of this study suggest that the HPA-5b allele is a genetic risk factor for the development of OVC in patients with SCA. This allele could be explored as a target for the development of new therapeutic approaches. SN - 0042-9007 UR - https://www.unboundmedicine.com/medline/citation/15355504/Polymorphism_of_the_human_platelet_antigen_5_system_is_a_risk_factor_for_occlusive_vascular_complications_in_patients_with_sickle_cell_anemia_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0042-9007&date=2004&volume=87&issue=2&spage=118 DB - PRIME DP - Unbound Medicine ER -